C50.129
BillableMalignant neoplasm of central portion of unspecified male breast
HCC Category Mapping
What This Code Means
Cancer in the central portion of a male breast where the specific side (left or right) is not identified.
Coding Tips
- •This unspecified code should only be used when laterality cannot be determined from documentation
- •Query the provider if possible to determine whether the cancer is in the right or left breast for more specific coding
Clinical Significance
Malignant neoplasm of the central portion of unspecified male breast represents invasive breast cancer requiring staging, treatment planning, and ongoing surveillance. Breast cancer is risk-adjusted because it demands significant healthcare resources including surgery, radiation, chemotherapy, hormonal therapy, and long-term monitoring. Male breast cancer accounts for less than 1% of all breast cancers, making accurate gender-specific coding particularly important for tracking and research. The unspecified laterality indicates documentation does not identify the affected side, which should trigger a provider query.
Documentation Requirements
- ✓Pathologic confirmation of invasive malignancy (biopsy with histologic type — ductal, lobular, etc.)
- ✓Laterality must be queried if not documented — right or left breast
- ✓Gender documented as male to support gender-specific code selection
- ✓Quadrant or subsite location: central portion
- ✓Tumor size (T stage) and grade
- ✓Lymph node status (N stage) — axillary, sentinel node biopsy results
- ✓Estrogen receptor, progesterone receptor, and HER2 status
- ✓Stage grouping (I-IV)
- ✓Current treatment status (active treatment, hormonal therapy, surveillance)